Drug profile · INN
gepirone hydrochloride
EXXUA
gepirone hydrochloride (EXXUA) is a serotonin 1a (5-ht1a) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — gepirone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
gepirone hydrochloride (EXXUA) is a serotonin 1a (5-ht1a) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1a (5-HT1a) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is gepirone hydrochloride?
gepirone hydrochloride (EXXUA) is a serotonin 1a (5-ht1a) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gepirone hydrochloride?
EXXUA is a marketed brand name for gepirone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gepirone hydrochloride?
gepirone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.